Junior Gold and Mining Stock News Alert; Lomiko (TSX-V: LMR; OTC: LMRMF) Completes Phase I Exploration at Vines Lake Gold Property

Vancouver, BC - July 25, 2011 (Investorideas.com mining stocks newswire) � Junior gold stock, LOMIKO METALS INC. (TSX-V:LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7) reports the following news:
Click here to view the FULL, VISUAL INFOGRAPHIC version of the release, or enter in this URL: http://revolvemarketing.ca/ pressrelease/?p=65

LOMIKO METALS INC.'S Exploration Manager Lesley Hunt reports that Lomiko has completed Phase I of the 2011 Exploration Program at Vines Lake. The Exploration team has completed soil geochemistry survey at 50m spaced sample sites on 200m spaced lines. The soil grid covers a total of 74.7 line kilometers including the claim lines. A total of 1,358 soil samples were taken, bagged and sent to Stewart Group - Eco Tech Division in Kamloops, BC for analysis and further assaying. The property has several lakes and swamps where no soil samples could be obtained.
The program is designed to target both potentially high-grade gold vein systems, as seen at the adjacent Table Mountain Mine, in addition to the prospect of intrusion related mineralization.
Phase II of the 2011 Exploration Program which includes geological mapping and diamond drilling has commenced. Currently geologists are mapping known airborne geophysical anomalies and pending results will target geochemical soil anomalies. Diamond drilling will then further explore the resulting geophysical, geochemical and geological mapping anomalies in priority.
Lomiko holds the rights to three contiguous mineral tenures, totaling 1,169 Ha (2,888 Acres) located in the southwestern corner of the Cassiar Gold District or 'Cassiar Gold Camp'.
Due to the property's close proximity to formerly producing mines with a proven history in the Cassiar Mining Camp, it is the opinion of the company that potential exists on the 100% owned Vines Lake Property for discovering new high-grade gold vein systems. Also, there is a potential for other intrusion related mineralization in proximity to the Cassiar Batholith and its associated boundary contacts, over which Lomiko's Vines Lake property claims are located.
Cassiar Area Highlights:

• A new company with Chinese investors known as China Minerals Mining Corporation is located adjacent to the property.
• A fully permitted 270 tonne per day, gravity and flotation mill, power plant, assay laboratory and tailings impoundment facility is owned by China Minerals.
• Approximately 316,000 ounces of gold have been produced at the adjacent Table Mountain Mine from 1979-2007 under various companies.
• Current Resource Estimates for the Table Mountain Mine are 21,471 tonnes grading 18.02 g/t indicated and 65,757 tonnes grading 24.3 g/t inferred were reported at the adjacent property in the May, 2010 NI43-101 Technical Report on the Table Mountain Property by C. Pearson and F.J. Bakker.

Vines Lake Highlights:

• Two significant anomalies have been identified by geophysical surveys. The claims cover formations of the Sylvester group, which are known to contain productive zones of gold mineralization in the area.
• The Vines Lake Property is located approximately two kilometres southwest of the former Erickson gold mine.
• Highway 37 N bisects the property north to south providing excellent year-round access.

Mr. Garth Kirkham, P.Geo is a Director of Lomiko Metals Inc. in addition to being the Qualified Person for the Vines Lake Project and has reviewed the technical data in this news release.
Click here to view the FULL, VISUAL INFOGRAPHIC version of the release, or enter in this URL: http://revolvemarketing.ca/ pressrelease/?p=65
On behalf of Lomiko Metals Inc,
A. Paul Gill, President & CEO
We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
647-607-6023
Bay Street Connect
info@lomiko.com
Lomiko Metals Inc.
www.lomiko.com

Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Lomiko Metals Inc. (TSX-V: LMR) three month showcase gold stock on Investorideas.com and all related mining portals and blogs (one thousand per month)
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

Water News; American Micro Detection Systems announces the availability of Real Time Elemental X-ray Fluorescence (REX) dissolved metal analysis instrument

Stockton, CA - July 22, 2011 (Investorideas.com Newswire) - American Micro Detection Systems, Inc. announces the availability of the Real Time Elemental X-ray Fluorescence (REX) dissolved metal analysis instrument slated for 15 August, 2011. REX has gone through exhaustive development and testing at the company's Livermore, CA research & development center for the past 3 years. REX was awarded the Artemis Top 50 award for 2011 at the Canadian Water Summit in Ontario. REX provides Dissolved Metal Analysis of water and other low viscosity to low parts per billion (ppb) levels to 3 Sigma accuracy.

REX provides users with the capability to analyze metals during actual flow conditions, "At-the-Source-Of-Interest".

• Once parameters are set, REX needs no user interface or human interaction.
• REX integrates into Smart Water Grid Technologies, providing User Control Centers with continual data feedback, control, interaction and monitoring solutions.
• REX stores data and communicate results to any location in the world.
• Acting as an autonomous process control instrument; REX sends the user an alarm, closing a valve, alerting personnel to any condition changing within the user's process.
• REX is self calibrating and requires no consumables.

Badger Meter, Inc. (NYSE: BMI) recently signed a worldwide distributorship agreement for REX in the municipal water space.
About AMDS, Inc.
American Micro Detection Systems, Inc. (AMDS, Inc.), is a privately held technology company located in Stockton, CA. that develops and manufactures innovative, real-time water analysis instrumentation working for a cleaner, safer environment for future generations
For further information, please see http://www.amdsinc.com or contact info@amdsinc.com.

Point Roberts, WA - July 22, 2011 (Investorideas.com Energy Newswire) - www.InvestorIdeas.com, a leader in sector research including oil and gas stocks, releases a trading alert and stock chart for showcase energy company, Osage Exploration and Development, Inc. (OTCBB: OEDV). The company has had a five day move from the $0.30 range to today’s high of $0.38, following news July 14 th, that their Nemaha Ridge Mississippian prospect has now reached 12,000net mineral acres.
Osage Exploration and Development, Inc. (OTCBB: OEDV) is trading up at $0.38, up 0.03 (8.57%) in early morning trading.
Visit the company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/

Recent Osage News:
Osage (OTCBB: OEDV), Slawson, and USEDC Continue to Expand Horizontal Mississippian Project
SAN DIEGO, CA - July 14, 2011 (Investorideas.com energy stocks newswire) - Osage Exploration and Development, Inc. (OTCBB: OEDV) along with its partners, Slawson Exploration Company, Inc. and U.S. Energy Development Corporation are pleased to announce that their Nemaha Ridge Mississippian prospect has now reached 12,000net mineral acres, an increase from 10,000 net acres announced in late May 2011.
Full news: http://www.investorideas.com/CO/OEDV/ news/2011/07141.asp
Land Acquisition in Nemaha Ridge Mississippian Project Now in Excess of 11,000 Net Mineral Acres Reports Osage (OTCBB: OEDV) and Partners, Slawson and USEDC
Full news: http://www.investorideas.com/CO/OEDV/news/2011/06202.asp
Osage (OTCBB: OEDV) Joint Ventures Its 10,000 Acre Horizontal Mississippian Nemaha Ridge Project
SAN DIEGO - May 26, 2011 (Investorideas.com energy stocks newswire) - Osage Exploration and Development, Inc. (OTCBB: OEDV) is pleased to announce that it has closed an agreement whereby Slawson Exploration Company, Inc. and U.S. Energy Development Corporation have acquired 45% and 30% respectively of Osage’s Nemaha Ridge project in Oklahoma for gross consideration of $4,875,000.00 plus a 10% net carry on the first three horizontal Mississippian wells.
Full News: http://www.investorideas.com/CO/OEDV/news/2011/05261.asp
About Osage Exploration and Development, Inc. (OTCBB: OEDV)
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Research more oil and gas stocks with the oil and gas stock directory at Investorideas.com – lists over 600 stocks including Bakken stocks
http://www.investorideas.com/OGSN/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming .
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
C Van Zant: 800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

Osage Exploration and Development, Inc. (OEDV.OB) is a showcase oil and gas stock on Investorideas.com
Visit the company showcase profile at Investorideas.com
Request news and stock alerts for Osage Exploration and Development, Inc. (OEDV.OB)
Disclosure : (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

NASDAQ Top Percentage Gainers: MRNA, MLNX, DTLK, EGLE

POINT ROBERTS - July 22, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for July 21, 2011. Marina Biotech, Inc. was the top gainer on the exchange with the stock closing higher by about 30% on Thursday.

Marina Biotech, Inc. (NASDAQ:MRNA) was the biggest gaineron NASDAQ and soared 0.061 (29.76%) to $0.266. Earlier this week, the company announced that R. John Fletcher was elected to the Company's Board of Directors effective July 14, 2011, replacing Board member Chiang Li, Ph.D., M.D., who announced his retirement from the Marina Biotech board prior to the 2011 annual meeting of shareholders.
Mellanox Technologies, Ltd. (NASDAQ:MLNX) also rose 4.37 (15.06%) to $33.38 and made a new 52-week high of $34.57 following the company reported revenue of $63.3 million in the first quarter of 2011, up 15.1% from $55.1 million in the first quarter of 2011, and up 58.5% from $40 million in the corresponding quarter of 2010. The company earned $2.1 million or 6 cents a share.
Datalink Corporation (NASDAQ:DTLK) climbed 1.02 (12.90%) to $8.93 and made the new 52-week high of $9.73 folloiwng the company posted better-than-expected quarterly results and forecast a strong third quarter driven by the addition of new customers and strong demand for data storage.
The company said that it earned 19 cents a share on revenue of $82.5 million.
Eagle Bulk Shipping Inc. (NASDAQ:EGLE) surged 0.24 (9.68%) to $2.72. The company will report its financial results for the second quarter ended June 30, 2011, after the close of stock market trading on Wednesday, August 3rd.
Investorideas.com Free Investor Tools;
Sign up for the free investor news and stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Biotech/Pharma Trading Alert for BioSante (NASDAQ: BPAX)

Point Roberts, WA, LINCOLNSHIRE, Ill - July 22, 2011 - Investorideas.com, a leader in sector stock research for independent investors , issues a trading alert for specialty biotech/pharma stock, BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for July 22 nd . The stock traded as high as $3.73 on July 21 st following news of the exclusive worldwide license of its Melanoma Vaccine to The John P. Hussman Foundation.
The stock is on an upward trend based on recent analyst coverage and bullish price targets, gaining almost 40% in the past month.
3 Month Chart

News Excerpt: BioSante Pharmaceuticals (NASDAQ: BPAX) Signs Melanoma Vaccine License
"LINCOLNSHIRE , Ill. - July 21, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced an exclusive worldwide license of its Melanoma Vaccine to The John P. Hussman Foundation, a charitable foundation that supports research to address life-threatening medical conditions and significant disabilities. BioSante received $100,000 on signing the license and is eligible for up to $39 million in milestone payments, plus royalties on sales. Additionally, the Hussman Foundation has committed up to approximately $11 million in Melanoma Vaccine clinical development funding. Also, BioSante will receive between 15 and 33 percent of any sublicense payments received by the Hussman Foundation depending on the timing of any sublicense by the Foundation to a corporate sub-licensee.
BioSante's Melanoma Vaccine is one of a portfolio of BioSante cancer vaccines in development including vaccines for leukemia, breast and pancreatic cancer. BioSante's Melanoma Vaccine was granted Orphan Drug designation by the FDA earlier this year.
"We are excited by the Melanoma Vaccine license with the Hussman Foundation since the Foundation's funding will allow for the first human clinical trial of our Melanoma Vaccine," said Stephen M. Simes, BioSante's president & CEO. "Importantly, the Foundation intends to move rapidly into human clinical trials. Assuming a successful outcome of the first Phase I clinical trial, the Foundation will fund a Phase II clinical trial with the objective of obtaining further clinical evidence and engaging a corporate sponsor for Phase III clinical trials."
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as “will," “continue," “could," “believe," “intends," “continue," “expects," “anticipates," “estimates," “may," other words of similar meaning, derivations of such words or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact BioSante:
For info about BioSante Pharmaceuticals, Inc
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220
azachary@mckinneychicago.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com :
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks. Investorideas.com is known for its comprehensive stock directories in each sector and sector specific newswires.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com
800 665 0411 cvanzant@investorideas.com

Energy Stocks; Aroway Energy Inc. (TSX-V:ARW; PINK:ARWJF) Acquires Land

CALGARY, ALBERTA - July 21, 2011 (Investorideas.com energy stocks newswire) � Aroway Minerals Inc. (TSX-V:ARW; PINK:ARWJF) (www.arowayenergy.com) (the "Company") Reports that the Company together with its Joint Venture Partner (the "Partnership") was successful in acquiring fifteen (15) sections of land, consisting of thirteen (13) sections of shallower rights with drill depths to 1,500 meters and two (2) sections of deeper rights, at a recent Alberta crown land sale. The newly acquired lands are adjoining the Partnership's existing core area land holdings and approximately half the lands are covered with seismic data. Aroway now has access to approximately 90 sections of rights.

Due to heavy rains in the area, testing on the Company's third well of the 2011 drill program has been delayed. Testing operations on the third well will therefore begin later this week followed by a re-completion program on the various recently acquired wellbores. Production results will be released on this well, and the recompletions when the wells have produced at reliable, economic rates.
Chris Cooper, President & CEO, commented, "We are extremely pleased with the results at the recent land sale. The addition of the new lands compliment the already impressive and highly prospective land package that we have access to in our core area in the Peace River Arch."
About Aroway Energy Inc.
Aroway Energy Inc. is a Western Canadian junior oil and gas production and exploration company participating in "non-operated" Peace River Arch oil and gas exploration prospects, through a joint venture partnership. Aroway is currently producing approximately 225 boe/day of oil, gas liquids and gas net to Aroway
ON BEHALF OF AROWAY ENERGY INC.
Chris Cooper, President
BOEs may be misleading, particularly if used in isolation. A BOE conversion ratio of 6 Mcf: 1bbl is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
Judy-Ann Pottinger
Aroway Energy Inc.
(604) 304-4090 or Cell: (604) 617-5290
(604) 909-2679 (FAX)
jpottinger@arowayenergy.com
www.arowayenergy.com
(647) 258-3311 or Toll Free: (888) 258-3323
Investor Cubed Inc.
(416) 363-7977 (FAX)
info@investor3.ca
Disclosure: ARW is a paid advertising client on Investorideas.com and our energy, natural gas, and oil and gas portals.

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Mining and Gold Stocks News; Lomiko (TSX-V: LMR; OTC: LMRMF) Completes Phase I Exploration at Gold Property; Phase II Including Drilling to Commence in August

Vancouver, BC - July 21, 2011 (Investorideas.com mining stocks newswire) � LOMIKO METALS INC. (TSX-V:LMR, OTC: LMRMF, Europe: ISIN: CA54163Q1028, WKN: A0Q9W7) -
Click here to view the FULL, VISUAL INFOGRAPHIC version of the release, or enter in this URL: http://revolvemarketing.ca/ pressrelease/?p=65

LOMIKO METALS INC.'S ("Lomiko" or "the Company") Exploration Manager Lesley Hunt reports that Lomiko has completed Phase I of the 2011 Exploration Program at Vines Lake. The Exploration team has completed soil geochemistry survey at 50m spaced sample sites on 200m spaced lines. The soil grid covers a total of 74.7 line kilometers including the claim lines. A total of 1,358 soil samples were taken, bagged and sent to Stewart Group - Eco Tech Division in Kamloops, BC for analysis and further assaying. The property has several lakes and swamps where no soil samples could be obtained.
The program is designed to target both potentially high-grade gold vein systems, as seen at the adjacent Table Mountain Mine, in addition to the prospect of intrusion related mineralization.
Phase II of the 2011 Exploration Program which includes geological mapping and diamond drilling has commenced. Currently geologists are mapping known airborne geophysical anomalies and pending results will target geochemical soil anomalies. Diamond drilling will then further explore the resulting geophysical, geochemical and geological mapping anomalies in priority.
Lomiko holds the rights to three contiguous mineral tenures, totaling 1,169 Ha (2,888 Acres) located in the southwestern corner of the Cassiar Gold District or 'Cassiar Gold Camp'.
Due to the property's close proximity to formerly producing mines with a proven history in the Cassiar Mining Camp, it is the opinion of the company that potential exists on the 100% owned Vines Lake Property for discovering new high-grade gold vein systems. Also, there is a potential for other intrusion related mineralization in proximity to the Cassiar Batholith and its associated boundary contacts, over which Lomiko's Vines Lake property claims are located.
Cassiar Area Highlights:

• A new company with Chinese investors known as China Minerals Mining Corporation is located adjacent to the property.
• A fully permitted 270 tonne per day, gravity and flotation mill, power plant, assay laboratory and tailings impoundment facility is owned by China Minerals.
• Approximately 316,000 ounces of gold have been produced at the adjacent Table Mountain Mine from 1979-2007 under various companies.
• Current Resource Estimates for the Table Mountain Mine are 21,471 tonnes grading 18.02 g/t indicated and 65,757 tonnes grading 24.3 g/t inferred were reported at the adjacent property in the May, 2010 NI43-101 Technical Report on the Table Mountain Property by C. Pearson and F.J. Bakker.

Vines Lake Highlights:

• Two significant anomalies have been identified by geophysical surveys. The claims cover formations of the Sylvester group, which are known to contain productive zones of gold mineralization in the area.
• The Vines Lake Property is located approximately two kilometres southwest of the former Erickson gold mine.
• Highway 37 N bisects the property north to south providing excellent year-round access.

Mr. Garth Kirkham, P.Geo is a Director of Lomiko Metals Inc. in addition to being the Qualified Person for the Vines Lake Project and has reviewed the technical data in this news release.
Click here to view the FULL, VISUAL INFOGRAPHIC version of the release, or enter in this URL: http://revolvemarketing.ca/ pressrelease/?p=65
On behalf of Lomiko Metals Inc,
A. Paul Gill, President & CEO
We seek safe harbor. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact:
647-607-6023
Bay Street Connect
info@lomiko.com
Lomiko Metals Inc.
www.lomiko.com

Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. Lomiko Metals Inc. (TSX-V: LMR) three month showcase gold stock on Investorideas.com and all related mining portals and blogs (one thousand per month)
Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Green Energy Car Stocks Trading Alert; TSLA, HEV, AONE, (OTCBB: EVCA)

Point Roberts WA- July 21, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in cleantech investor research, reports on trading for renewable energy stocks in the electric car and battery sector for 20th July.

Chargemaster, a company specialising in electric vehicle infrastructure, says it will provide 4,000 charging points across 100 towns and cities in the UK by the end of 2012.
So far Britain has about 1,000 charging points through the Government-backed scheme Plugged in Places; therefore the new programme, called Polar, will significantly increase the country's infrastructure.
Tesla Motors has signed a $100 million deal to build the power train for Toyota's electric Rav4, the Palo Alto Company reported Wednesday in a government filing.
Tesla Motors Inc (NASDAQ:TSLA) ended the day at $28.69, up 0.80 (2.87%).
Ener1, Inc. (NASDAQ:HEV) climbed 5.53% to $1.05. Earlier this week, the lithium-ion battery maker Ener1 and Wanxiang Electric Vehicle Co, a division of the Chinese conglomerate Wanxiang Group Corporation, have received approval from the Chinese government for their joint venture to co-manufacture lithium-ion energy storage systems for the China market.
A123 Systems, Inc. (NASDAQ:AONE) climbed 0.55% to $.51. The company is scheduled to report its second quarter 2011 financial results for the period ended June 30, 2011 after the market close on Thursday, August 4, 2011.
EVCARCO INC (OTC: EVCA) surged 0.0018 (18.00%) to close at $0.0118...
Advanced Battery Technologies, Inc. (NASDAQ:ABAT ) surged 0.19 (14.50%) to $1.50.
China Ritar Power Corp. (PINK: CRTP) closed with a gain of 6.76% to $0.790.
Electric Car/ Green Car Company Snapshot
EVCARCO (OTC.BB: EVCA) - Green, Electric Cars and Natural Gas Vehicles
EVCARCO (OTC.BB:EVCA) (www.evcarco.com) is the first automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles.
Visit the EVCA profile at Investorideas.com - http://www.investorideas.com/CO/EVCA/
Research electric car stocks and green auto stocks , lithium stocks - with the renewable energy stocks directory Research over 1300 green stocks - Investors also have the option to access the directory as part of the Investor Ideas Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 10 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
More Research: get a full list of global publicly traded green stocks
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit our green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or
www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Disclosure: Investorideas is compensated by featured green companies EVCARCO (OTCBB: EVCA) is a showcase stock at Investorideas.com and compensated the site 500,000 144 shares in lieu of cash compensation.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information contact:
Email: dvanzant@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.Investorideas.com

Energy Stocks News; Robert McIntosh, President & C.E.O. of American Petro-Hunter, Inc. (OTCBB: AAPH), Goes Over the Details of Recent American Petro-Hunter, Inc. News in New Audio Interview at SmallCapVoice.com

AUSTIN, Texas � July 21, 2011 (Investorideas.com energy newswire) - SmallCapVoice.com, Inc. announced today that a new audio interview featuring American Petro-Hunter, Inc. (OTC.BB:AAPH) is now available. The interview can be heard at http://smallcapvoice.com/ blog/7-20-11 -audio-interview-with-american -petro-hunter- otcbb-aaph.

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks and audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and investor information sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/ services.html.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
To find out more about American Petro-Hunter, Inc. (OTC.BB:AAPH), visit our website at www.americanpetrohunter.com
Contact:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
Contact for SmallCapVoice.com:
Stuart T. Smith
512-267-2430
info@smallcapvoice.com

Visit the AAPH showcase profile at Investorideas.com
Request News and Info on AAPH
Disclosure, Disclaimer/ AAPH is a paid advertising client on Investorideas.com.
American Petro-hunter Inc. (AAPH.OB) showcase energy stock on Investorideas.com and energy portals and blogs (averages two thousand per month)

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

NASDAQ Top Winners July 20th; SINO, CTDC, REVU, IDCC

POINT ROBERTS, July 21, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for trading July 20, 2011.

Sino-Global Shipping America, Ltd. (NASDAQ:SINO) was the biggest gaineron NASDAQ soaring 11.75 (28.31%) to $53.26, following news its board was reviewing options including a sale of patents or the whole company. The company is a developer of wireless technology with a sizable patent portfolio.
China Technology Development Group Corp. (NASDAQ:CTDC) moved 0.41 (38.95%) to $1.46 after the company announced it has reaffirmed its commitment to solar projects investment and plans to file its interim report for 2011 with the SEC by the end of August.
The Princeton Review, Inc (NASDAQ:REVU) climbed 0.071 (29.50%) to $0.310 after the company reported it has signed a new multi-year master publishing agreement with Random House, Inc. for the rights to publish all print and electronic books branded and trademarked by The Princeton Review.
InterDigital, Inc. (NASDAQ:IDCC) surged 15.41 (28.93%) to $68.67 after rising more than 30% in the previous trading session as the company is exploring potential alternatives including a sale.
Investorideas.com Free Investor Tools;
Sign up for the free investor news and stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Pharma and Biotech News; BioSante Pharmaceuticals (NASDAQ: BPAX) Signs Melanoma Vaccine License

LINCOLNSHIRE, Ill. - July 21, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced an exclusive worldwide license of its Melanoma Vaccine to The John P. Hussman Foundation, a charitable foundation that supports research to address life-threatening medical conditions and significant disabilities. BioSante received $100,000 on signing the license and is eligible for up to $39 million in milestone payments, plus royalties on sales. Additionally, the Hussman Foundation has committed up to approximately $11 million in Melanoma Vaccine clinical development funding. Also, BioSante will receive between 15 and 33 percent of any sublicense payments received by the Hussman Foundation depending on the timing of any sublicense by the Foundation to a corporate sub-licensee.

BioSante's Melanoma Vaccine is one of a portfolio of BioSante cancer vaccines in development including vaccines for leukemia, breast and pancreatic cancer. BioSante's Melanoma Vaccine was granted Orphan Drug designation by the FDA earlier this year.
"We are excited by the Melanoma Vaccine license with the Hussman Foundation since the Foundation's funding will allow for the first human clinical trial of our Melanoma Vaccine," said Stephen M. Simes, BioSante's president & CEO. "Importantly, the Foundation intends to move rapidly into human clinical trials. Assuming a successful outcome of the first Phase I clinical trial, the Foundation will fund a Phase II clinical trial with the objective of obtaining further clinical evidence and engaging a corporate sponsor for Phase III clinical trials."
"We at the Hussman Foundation have very personal family reasons for wanting to fund work in melanoma research," said John P. Hussman, PhD, director of the Hussman Foundation. "In our ongoing partnership with leading melanoma and cancer specialists, we are increasingly encouraged that targeting the immune system using BioSante's cancer vaccine may be a viable treatment approach for this most immunogenic of cancers. We chose to license and fund BioSante's Melanoma Vaccine based on its potential to enhance the effective treatment options that are available to melanoma patients in need," Dr. Hussman added.
The first Phase I clinical trial of the Melanoma Vaccine is expected to begin within the next several months. The clinical trial protocol is being finalized at this time and Melanoma Vaccine has been produced for the trial.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
About the Hussman Foundation
The mission of the John P. Hussman Foundation is to provide life-changing assistance through medical research, education, and direct aid to vulnerable individuals having urgent needs or significant disabilities. The Hussman Foundation seeks to �tip the balance� in critical areas where research or intervention can significantly alter the course of individual lives, and where resources would otherwise not be available. Additional information is available online at: www.hussmanfoundation.org.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as "will," "continue," "could," "believe," "intends," "continue," "expects," "anticipates," "estimates," "may," other words of similar meaning, derivations of such words or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
McKinney/Chicago
Alan Zachary
(312) 944-6784 ext. 316
azachary@mckinneychicago.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com

Mining Stocks; TurkPower Corporation (OTC.BB: TRKP) Announces Agreement With Beneficiation Plant Manufacturer and Commencement of Mining Operations at Its Kuluncak Site

NEW YORK, NY - July 21, 2011 (Investorideas.com Mining stocks Newswire) - TurkPower Corporation (OTC.BB:TRKP) (the "Company") is pleased to announce the signing of a cooperation agreement between its subsidiary Maksor Madencilik Sanayi Ve Ticaret Anonim Sirketi (hereafter "Maxore") with the Austrian beneficiation plant manufacturer The Standard GmbH ("Standard") for its Kuluncak iron ore project. TurkPower and Maxore will be closely cooperating with Standard in engineering, research and development, project development and product development of machinery and equipment for its Kuluncak project as well as other mining projects in the future.

The first beneficiation plant for the Kuluncak iron ore mine is a mobile dry beneficiation plant with a capacity of 48,000 - 60,000 tons per month and will be operational by August 2011. In a second phase, a wet beneficiation plant will be installed at the Kuluncak site, allowing for wet beneficiation and higher capacity as early as April 2012. Standard's beneficiation technology and equipment increases the Kuluncak iron ore grade from 58 - 62% to 62 - 65% Fe content.
Open-pit mining operations commenced at the Kuluncak site in May after more than two years of exploration study, ore extraction planning, machinery and equipment selection, waste dump site selection and planning, and ore extraction designing from narrow veins, tabular and massive deposits utilizing mechanized methods. The Company will report soon in more detail about its projected iron ore production and sales for 2011.
About the Kuluncak Property
The Kuluncak iron ore mine is an open-pit mine, which can be operated from April/May to November and is expected to produce 550,000 metric tons of iron ore per season. According to a two-year feasibility study conducted in 2008 and 2009, the mine has estimated reserves of 20,900,000 metric tons for a net value of approximately $3bn based on current market price for 58 - 62%-grade iron ore. The feasibility study was conducted by one of the world's leading mining companies, which concluded: "The project offers great value for money if a small mine is what one is looking for." The mine has been operational since June 2011, and has more than 140,000 metric tons of iron ore in inventory which will be sold starting in August. The Company expects to sell a total of up to 220,000 tons of iron ore in 2011, and further increase production in the following years.
About TurkPower Corporation
TurkPower Corporation (OTC.BB:TRKP) is a Turkish-American consulting and service operations firm with a strong focus on the booming Turkish energy and mining industries. TurkPower offers its domestic and international clients consulting services and acts as a full service operator for wind, hydro, solar and coal power plants in Turkey. In addition to its energy business, TurkPower aims at becoming a substantial player in the Turkish mining industry by acquiring and consolidating operational mines with proven reserves, utilizing economies of scale to increase returns.
About Turkey

• 73m inhabitants
• 17th-largest economy in the world
• 2nd-fastest growing economy in the world
• Member of NATO, OECD, OSCE and G-20
• Classified as a democratic, secular and developed nation by the CIA

Turkey is an important player in the international minerals market due to its wealth of reserves, considerable production capacity and geographical advantages for transportation and shipping. Ranked 28th in global mining production, Turkey also ranks 10th in terms of variety and quantity of undeveloped minerals.
Turkey is the 2nd-fastest growing economy in the world, the 4th-largest shipbuilder, the 10th-largest steel-producing nation, a leading electronics manufacturer for Eastern Europe and the Middle East, and has recently surpassed Italy in terms of automobile production.
Safe Harbor Statement
The statements by our officers, and other statements regarding optimism related to the business, consulting, service operations, expanding exploration and development activities and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business and subject to successful financing. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many risk factors that affect the industry the Company operates in and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere.
Contact:
TurkPower Corporation
100 Park Avenue
New York, New York 10017
T 212-984-0628
F 212-880-6499

TurkPower Corporation (OTC.BB: TRKP) is a showcase mining stock on Investorideas.com
Visit the showcase profile for TurkPower Corporation (OTC.BB: TRKP) to learn more about the company
Request News alerts for TurkPower Corporation (OTC.BB: TRKP)

Disclosure: Investorideas.com is compensated by TurkPower Corporation: (OTC.BB:TRKP) May 18 2011 (6 months- 3500 per month 150,000 144 shares)

BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Social Networking Stocks Trading News Alert; (OTCBB:ECDC), (OTCBB:DOGO), (NasdaqGM: FFN), (NYSE: RENN)

POINT ROBERTS, Wash., July 20,2011 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research including tech stocks issues an investor alert for social networking stocks for trading July 20th.

Wall Street can't seem to get enough of social networking stocks . As investors wait for Facebook, Groupon and Zynga Inc IPO's , smaller companies are entering the social networking space with new applications and innovation .
East Coast Diversified Corporation (OTCBB:ECDC), through its subsidiary EarthSearch Communications, Inc., plans to develop a portfolio of GPS related commercial and social networking mobile applications under its new division, EarthSearchMobile, Inc.
"EarthSearchMobile will integrate EarthSearch's current GPS/RFID technology into an easy to use mobile interface to enhance our current product offerings for our existing clients. Other applications to be developed will include social networking activities related to commercial information and retail business sales," said ECDC Chairman and CEO, Kayode Aladesuyi
Digagogo Ventures Corp.(OTCBB:DOGO ), a provider of information and communications technology, announced today it has completed an asset purchase agreement for the acquisition of Swebby Inc. The stock is trading up on news with significant volume. The Company is developing a digital sales and distribution network designed to connect households together and enable individuals to buy or sell items within a local community.
Bizzingo, Inc .(OTCBB: BIZZ ) and IBG.com, Inc. reported they have signed a Letter of Intent (LOI) to confirm discussions concerning a merger or some other form of business arrangement between the two companies. The combined services of both companies would include online marketing, reputation management, and a social network designed for businesses, positioning Bizzingo to help businesses connect, promote and protect their brands online. The stock was up on the news on early trading.
Social Networking Stocks Trading Snapshot (at time of release)

• BIZZINGO, INC. (OTCBB: BIZZ ) trading at $0.73, up 0.02 (2.82%)
• East Coast Diversified Corporation (OTCBB:ECDC), trading at $0.02 on over 100,000 shares in volume
• Digagogo Ventures (OTCBB:DOGO) trading at $0.54 on over 900,000 shares in volume
• FriendFinder Networks Inc.(NasdaqGM: FFN ) trading at $4.60 , up 0.03 (0.66%)
• LinkedIn (NYSE: LNKD ) trading at $97.40 on over 800,000 shares in volume
• Renren Inc. (NYSE: RENN ) trading at $10.53, on over 1 Million shares in Volume

Research Social Networking stocks:
Visit the Investorideas.com Social Networking Stocks Directory preview page:
http://www.investorideas.com/TSS/Social_Networking_Stocks.asp
Showcase Stock :
East Coast Diversified Corporation (OTCBB:ECDC)
Visit the showcase page at Investorideas.com
http://www.investorideas.com/CO/ECDC/
Sign up for the free investor news letter and get stock alerts http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
Disclosure : ECDC is a paid advertising company on Investorideas.com : four thousand per month
Source - Investorideas.com
800-665-0411 - dawn@investorideas.com, cvanzant@investorideas.com

Gold and Mining Stocks Trading Alert: (OTC:RFXRF), (TSX-V: YLL), (TSX.V: CUI), GLD, ABX


POINT ROBERTS - July 20, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, including gold and mining stocks reports on trading in junior and leading gold mining stocks for July 19th.

After gaining for the ten straight days, prices of Gold retreated on Tuesday from its record high as some rays of hope for the U.S. economy and a resolution for the European sovereign-debt crisis lessened the metal’s safe-haven demand.
Gold for August delivery closed $1.30, or 0.1%, lower to $1,601.10 an ounce on the Comex division of the New York Mercantile Exchange. It made another intraday record high of $1610.70.
In electronic trading after the settlement, the yellow lost over $15 an ounce, trading around $1,585 an ounce after President Barack Obama praised a $3.7 trillion deficit-reduction plan and hinted at a possibility of bipartisan agreement soon.
Trading Snapshot

• RUNNING FOX RES CORP (Public, PINK:RFXRF) surged 10.835 to $0.199.
• Yale Resources Ltd (Public, CVE:YLL) climbed 0.010 (16.67%) to $0.07.
• Currie Rose Resources Inc. (Public, CVE:CUI) added 8.57% to $0.190.
• SPDR Gold Trust (ETF) (NYSE:GLD) fell 1.22% to $154.66.The ETF has jumped about 13% so far this year and made a record high of $156.58 in Monday’s session.
• Goldcorp Inc. ( USA) (NYSE:GG) closed with a fall of 1.87% to $54.01.
• Barrick Gold Corporation ( USA) (NYSE:ABX) fell 0.47 (-0.96%) to $48.56.
• Agnico-Eagle Mines Limited ( USA) (NYSE:AEM) lost 3.40% to $63.48. NovaGold Resources Inc.

Featured Gold Stocks:
Learn more about our gold stocks at
http://www.investorideas.com/Gold_Stocks/
Running Fox (TSX-V: RUN) ( US OTC: RFXRF) ( FRANKFURT: C8Q)

Running Fox Gold and Silver Acquisition

Running Fox Resource Corp. now owns 100% of the advanced and developing Brett Gold and Silver Project in British Columbia, over 50 square kilometres, the majority is royalty free.
Cash on hand to start drill programs. 53 Million shares outstanding. 
The Company also owns other assets, and has cash flow from oil and gas. " Contact
Steven Schurman
Running Fox Resource Corp.
1 604 725 8868
www.foxgold.ca
Yale Resources Ltd. (TSX-V - YLL and Frankfurt - YAB)
Yale Resources Yale Resources Ltd. is an exploration and development company building value utilizing the Project Generator business model. With its Mexican operations based out of Hermosillo, Sonora, Yale is utilizing its extensive Mexican network to identify, acquire and advance projects of merit. Yale's partners are scheduled to spend greater than $1,000,000 on exploration on the Company's properties over the next 12 months.
Contact
Ian Foreman
info@yaleresources.com
www.yaleresources.com
Currie Rose Resources Inc. (TSX.V: CUI) (OTC: CUIRF)
Currie Rose Resources Inc. is a gold exploration company listed on the Toronto Venture Exchange under the symbol CUI-V, Frankfurt Exchange CDV, and U.S. OTC Market symbol CUIRF. The main focus is the Company's gold exploration projects in The Lake Victoria Gold Fields in Tanzania
IR contact
Harold Smith
harold@currierose.com
www.currierose.com
Investorideas.com Free Investor Tools;
Sign up for the free investor news and stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Research energy stocks, mining, agriculture stocks, cloud computing stocks and more…
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only eleven stock directories in leading sectors including renewable energy, water and energy stocks.
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com has been compensated by mining stocks YLL, CUI, SLTA, RUN, GBB, averaging five hundred per month as a showcase stock or paid news releases.
www.InvestorIdeas.com/About/Disclaimer.asp
For Additional Information and or interest in becoming a content /revenue partner:
Dawn Van Zant: 800-665-0411 - dvanzant@investorideas.com
Source - Investorideas.com

Biotech/Pharma Stocks Investor News Alert: AEMD, CAPS, ONTY, ANX, REGN

Point Roberts, WA - July 20, 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for July 19, 2011.

Biotech/Pharma Sector Snapshot Trading July 19 th
Aethlon Medical (OTCBB: AEMD ) traded lower by 0.0041 (-4.14%) to $0.0949. Last week, the stock moved up following a letter to shareholders discussing its Aethlon ADAPT™ (Adaptive Dialysis-Like Affinity Platform Technology) system, as an innovative medical device platform that provides a basis to create new therapeutic devices through the convergence of affinity drug agents and plasma membrane technologies.
The Aethlon ADAPT™ system provides a previously unrecognized commercialization pathway to antibody and other affinity drug developers, who should also appreciate a less onerous medical device regulatory pathway. We are already seeing evidence of our ADAPT™ system being the impetus for industry collaborations that offer new channels of early revenue generation.
Capstone Therapeutics Corp. (NASDAQ:CAPS) was one of the biggest gainers among the biotech companies and soared 44% to $0.36 on technical signal. The stock had corrected about 60% in the previous three-month before resumed its uptrend and over the past one week it has risen over 51%.
Oncothyreon Inc. (NASDAQ:ONTY ) shares also climbed 9.81% to $8.84 after a positive article released by seekingalpha.com.
ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) climbed 8.40% to $3.49 on high volume. Last week, it has secured work worth at roughly $165 million for numerous new projects and extensions to present projects in the Latin America, Asia-Pacific, EAME and North America areas.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) added 6.02% to $59.16. Last week, the company announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab (REGN88/SAR153191), a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor (IL-6R).
Biotech Medical Company Snapshot for Aethlon Medical (OTCBB: AEMD)
Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
Human studies have documented the ability of our Hemopurifier® to safely reduce viral load in both Hepatitis-C virus (HCV) and Human Immunodeficiency Virus (HIV) infected patients without the administration of antiviral drugs. However, our initial clinical and commercialization focus is to establish our Hemopurifier® as an adjunct therapy to enhance the benefit of both infectious disease and cancer treatment regimens. In this regard, we plan to commercialize our Hemopurifier® in India as we advance our clinical strategies in the United States and the European Union. In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:
1.Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2.Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3.Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4.Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.
The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings .
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011       
800-665-0411 - cvanzant@investorideas.com
Source - Investorideas.com

AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page

Disclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) is a paid advertising client ($one thousand five hundred per month, $five thousand per month in 144 stock)